Press Release Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer Jul 20
Press Release Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts Jul 17